Dr. Bora Lim and Josh Newby discussing their work in inflammatory breast cancer research, the challenges of securing funding for rare diseases, and the importance of patient involvement in academic centers. They also discuss the evolution of breast cancer treatment and research, the need for seed funding for rare diseases, and the importance of collaboration and adaptability in advancing cancer research and care.